September 29, 2026 What to Know: CMS Announces 2027 MA, Prescription Drug Rates CMS this week announced average premiums for Medicare Advantage (MA) and prescription drug plans would remain stable for 2027.
August 18, 2026 5 Things to Know: New Insights on Prior Authorization for Medicare, Medicaid, ACA Plans Insurers offering Medicare Advantage and Medicaid managed must now provide data about prior authorization, denials, and response times.
July 06, 2026 CMS Launches Medicare Pilot Program for GLP-1s CMS began covering certain GLP-1 medications through a new Medicare pilot program that launched this month.
June 15, 2026 CMS: Medicare Drug Price Negotiation is Here to Stay CMS is looking to make the Medicare Drug Price Negotiation Program permanent through a new proposed rule.
June 08, 2026 Concerning Outlook for Rural Hospitals A third of Pennsylvania’s rural hospitals are at risk of closing as payment for health care services continues to lag behind the cost of delivering care, a national report found.
March 17, 2026 Round 3 Medicare Drug Price Negotiations Begin The manufacturers of the 15 drugs selected for the next round of Medicare price negotiations all agreed to come to the table, setting the stage for the next phase to begin.
February 02, 2026 A Focus on Affordability More than 4 in 10 voters indicate the cost of health care will impact their votes heading into the midterm elections.
January 28, 2026 CMS Picks Next Drugs for Medicare Price Negotiations CMS this week announced the next 15 prescription drugs selected to participate in its Medicare drug price negotiation program for 2026.
December 03, 2025 CMS Announces Savings from Medicare Price Negotiation Program CMS will save $12 billion on the 15 commonly used drugs included in the second phase of the agency’s price negotiation program, federal officials announced late last month.